Doctor training aims to cut risky pill overload in seniors
NCT ID NCT06470308
First seen Feb 18, 2026 · Last updated Jun 23, 2026 · Updated 11 times
Summary
This study tests whether giving general practitioners special training on how to safely reduce medications (deprescribing) leads to fewer unnecessary prescriptions for older adults. About 200 patients aged 65+ who take at least 5 medications are taking part. The goal is to see if the training helps doctors lower the number of risky or unneeded drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYPHARMACY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Primary Care Facilities
Heraklion, Heraklion, Crete, 71303, Greece
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
educational intervention for general practitioners on deprescribing
What this could lead to
If successful, this could show that training doctors to review and reduce medications improves safety for older adults on multiple drugs.
What could go wrong
This is a small, early-stage study in one country (Greece). Results may not apply elsewhere, and the intervention may not lead to meaningful changes in prescribing.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.